<DOC>
	<DOCNO>NCT01888185</DOCNO>
	<brief_summary>This study design determine magnetic resonance imaging ( MRI ) measure use diagnose monitor progression Parkinson 's disease ( PD ) distinguish PD parkinsonism [ condition PD look-a-like disease progressive supranuclear palsy ( PSP ) multiple system atrophy ( MSA ) ] combine change certain protein body fluid relate iron ( Fe ) .</brief_summary>
	<brief_title>Identifying Biomarkers Parkinson 's Disease Using Magnetic Resonance Imaging ( MRI )</brief_title>
	<detailed_description>The lack vivo biomarker ( ) reflect Parkinson 's disease ( PD ) -related cell loss associate pathoetiological/physiological process nigrostriatal structure hinder discovery research limited ability evaluate disease-modifying therapy . Recent research generate excitement use DTI R2* MRI measure biomarker ( ) PD-related pathology nigrostriatal pathway , fall short lack understanding clinical implication biological/pathological underpinnings . Working closely National Institute Neurological Disorders Stroke ( NINDS ) Parkinson 's Disease Biomarkers Program ( PDBP ) , propose work investigate multimodal MRI technique combination fluid-based iron ( Fe ) protein profile serve vivo marker PD-related nigrostriatal pathology use biomarkers diagnose PD , follow progression , gain mechanistic understanding PD pathoetiology pathophysiology .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Parkinsonian Disorders</mesh_term>
	<mesh_term>Multiple System Atrophy</mesh_term>
	<mesh_term>Shy-Drager Syndrome</mesh_term>
	<mesh_term>Supranuclear Palsy , Progressive</mesh_term>
	<criteria>PD Subjects : 1 . Able willing sign consent form time initial enrollment subject decisionally impaired legal representative able willing sign consent form time enrollment . If subject becomes decisionally impaired course study , legal representative may sign addendum consent continue participation . 2 . MMSE score 15 great unless legal representative present . 3 . Idiopathic PD accord publish criterion . 4 . History adequate response dopaminergic therapy . 5 . History asymmetrical symptom onset MSA Subjects : 1 . Older 30 yr . 2 . Able willing sign consent form time initial enrollment subject decisionally impaired legal representative able willing sign consent form time enrollment . If subject becomes decisionally impaired course study , legal representative may sign addendum consent continue participation . 3 . MMSE score 15 great unless legal representative present . 4 . MSA accord publish criterion . 5 . History autonomic &amp; urinary dysfunction and/or severe cerebellar ataxia . PSP Subjects : 1 . Older 40 yr . 2 . Able willing sign consent form time initial enrollment subject decisionally impaired legal representative able willing sign consent form time enrollment . If subject becomes decisionally impaired course study , legal representative may sign addendum consent continue participation . 3 . PSP accord publish criterion . 4 . Vertical gaze palsy and/or slow vertical gaze/postural instability first year diagnosis . 5 . MMSE score 15 great unless legal representative present Controls : 1 . Older 21 yr . 2 . Able willing sign consent form . 3 . MMSE great 24 . PD Subjects : 1 . Unable legal representative/unwilling provide consent . 2 . Any condition precludes routine MRI ( e.g. , claustrophobia , pacemaker , severe scoliosis , etc. ) . 3 . History cerebrovascular disease neurological disorder . 4 . Major medical problem renal liver failure . 5 . Unstable , nonPDrelated medical condition . 6 . MMSE score less 15 unless legal representative present 7 . Use anticoagulant medication . 8 . Signs dementia . MSA Subjects : 1 . Unable legal representative /unwilling provide consent . 2 . Any condition precludes routine MRI ( e.g. , claustrophobia , pacemaker , severe scoliosis , etc. ) . 3 . History cerebrovascular disease neurological disorder . 4 . Major medical problem renal liver failure . 5 . Unstable , nonMSArelated medical condition . 6 . MMSE score less 15 unless legal representative present 7 . Use anticoagulant medication . 8 . Signs dementia . PSP Subjects : 1 . Unable legal representative /unwilling provide consent . 2 . Any condition precludes routine MRI ( e.g. , claustrophobia , pacemaker , severe scoliosis , etc. ) . 3 . History cerebrovascular disease neurological disorder . 4 . Major medical problem renal liver failure . 5 . Unstable , nonPSPrelated medical condition . 6 . MMSE score less 15 unless legal representative present 7 . Use anticoagulant medication . 8 . Signs dementia . Controls : 1 . Unable/unwilling provide consent . 2 . Evidence severe memory impairment sign dementia ( MMSE &lt; 24 ) . 3 . Any condition precludes routine MRI ( e.g. , claustrophobia , pacemaker , severe scoliosis , etc. ) . 4 . History cerebrovascular disease neurological disorder . 5 . Major medical problem renal liver failure . 6 . Unstable medical condition . 7 . Use anticoagulant medication . 8 . Signs dementia .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Parkinson 's</keyword>
	<keyword>PD</keyword>
	<keyword>nigrostriatal</keyword>
	<keyword>substantia nigra</keyword>
	<keyword>MRI</keyword>
	<keyword>DTI</keyword>
	<keyword>FA</keyword>
	<keyword>R2*</keyword>
	<keyword>Parkinson 's Disease Biomarkers Program</keyword>
	<keyword>PDBP</keyword>
	<keyword>ferritin</keyword>
	<keyword>transferrin</keyword>
	<keyword>Fe</keyword>
	<keyword>iron protein</keyword>
	<keyword>PSP</keyword>
	<keyword>MSA</keyword>
</DOC>